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Introduction
Plants are exposed to a large number of pathogenic 
fungi, against which they have developed a variety of 
defence mechanisms, including the synthesis of pro-
teins and peptides with antifungal activity (Theis and 
Stahl., 2004; Lucca et al., 2005). These proteins appear 
to be involved in either constitutive or induced resis-
tance to fungal attack. The identification of such pro-
teins could lead to the isolation of genes which could 
be employed in the development of transgenic plants 
with increased disease resistance as discussed by Fer-
reira et al., 2007. An example of plant potential antifun-
gal compounds with a possible use in agriculture and 
food processing are Ribosome Inactivating Proteins 
(RIPs). These proteins act as N-glycosidases and irre-
versibly block protein synthesis by modifying the large 
rRNA unit so that it is not longer recognized by transla-
tional elongation factors (Hartley et al., 1996). 
RIPs are widely distributed throughout the plant king-
dom and are active against ribosomes from different 
species. RIPs from cereals have high similarity to all oth-
er RIPs, retaining however characteristic features which 
group them into a distinct class which diversified sig-
nificantly during evolution. Three classes of RIPs have 
been identified (Balconi et al., 2010) and, although the 
enzymatic activities of RIPs have been shown in vitro, 
their role in plant defence is less clearly defined. In 
maize, pro-RIP, classified as a type3 RIP (Nielsen and 
Boston, 2001), is present in at least two forms encoded 
by non allelic genes, one expressed in the endosperm 
(Di Fonzo et al., 1988) and the other in leaf tissue (Bass 
et al., 1995). 
The RIP present in maize endosperm has been widely 
investigated (Motto and Lupotto, 2004; Balconi et al., 
2010 ); this protein is a cytosolic albumin with a molecu-
lar weight of 32 KDa (termed b-32) and is synthesized in 
temporal and quantitative coordination with the depo-
sition of storage proteins.  Similarly to other RIPs, maize 
b-32 is accumulated in the seed as an inactive pro-RIP 
precursor, which is converted into an active form by 
proteolytic processing. This involves the removal of 16 
amino acids from the N-terminus (residues 1-16 of pro-
RIP), several amino acids from the C-terminus (residues 
295-301), and 25 amino acids from the centre of the 
RIP polypeptide (residues 162-186) (Hey et al., 1995). 
In past years, maize b-32 was shown i) to enzymatically 
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Abstract
Fungi of the genus Fusarium are common plant pathogens mainly associated with cereal crops. In particular, 
Fusarium verticillioides Sacc. is the most common toxigenic fungus in maize worldwide, causing root, stalk, and 
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Plants act on the attack of pathogenic fungi through a complex network of active responses such as the 
production of proteins toxic or inhibitory to pathogens such as RIP (Ribosome-Inactivating-Protein). The RIP 
present in maize endosperm (termed b-32) has been widely investigated. Similarly to other RIPs, is accumulated 
in the seed as an inactive pro-RIP precursor, which is converted into an active form by proteolytic processing. To 
understand the relationships between structure and substrate specificity of the maize b-32 RIP protein, a series 
of recombinant b-32 sequences, by selective deleting of different domains (RIP b-32, RIP ∆N, RIP ∆C and RIP-
∆C (Ala), were prepared. Recombinant sequences were expressed in Escherichia coli to obtain high levels of 
recombinant proteins, which were subsequently tested for their potential ability to reduce both the colonization 
of F. verticillioides and fumonisin accumulation.
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inactive ribosomes and inhibit protein synthesis in vitro 
(Maddaloni et al., 1991); ii) to inhibit the growth of Rhi-
zoctonia solani mycelia in an in vitro bioassay and plant 
assays (Maddaloni et al., 1997). We have also shown 
that maize b-32 was effective in wheat transgenic lines 
as an antifungal protein by reducing Fusarium culmo-
rum head blight (FHB) (Balconi et al., 2007) and in 
maize transgenic lines reducing Fusarium verticillioides 
attack symptoms in leaf tissues assays (Lanzanova et al., 
2009). The role of maize b-32 in defence against patho-
gens was also suggested by an increased susceptibility 
of opaque-2 (o2) mutant kernels (in which the level of 
b-32 is decreased), to fungal attack (Loesch et al., 1976) 
and insect feeding. In addition, results obtained with 
inbred lines and their isogenic o2-mutants, tested in 
field experiments with artificial inoculation assays (KIA 
Kernel Inoculation Assay; SCIA Silk Channel Inoculation 
Assay) on adult plants, showed that o2 mutants were 
significantly more susceptible to F. verticillioides than 
the wild-type inbred lines (Balconi et al., 2005; Torri et 
al., 2011). 
To understand the relationships between structure and 
substrate specificity of the maize b-32 RIP protein, a se-
ries of recombinant b-32 sequences were prepared by 
selective deletion of different domains. Recombinant 
sequences were intracellularly expressed in Escherich-
ia coli to obtain high levels of recombinant proteins, 
which were subsequently tested for their potential abil-




A plasmid carrying the entire cDNA sequence of the 
maize b-32 gene was used as a source of recombinant 
sequences obtained with the of the Flexi Vector System 
(C8640 Promega). A tool for primer design (Figure 1a) 
is available on the Promega web site. The description 
of different b-32 sequences obtained is reported in 
Figure 1b
PCR
Gene sequences were amplified by PCR utilizing DNA 
(20 ng) as template, 10X Taq polymerase buffer, dNTP 
(200 µM), primers (0.1 µM) and Pfu DNA Polymerase (1. 
25U) in a final volume of 50 µL. Amplification was carried 
out over 35 cycles, after an initial denaturation step at 
95°C for 2 min. Each cycle consisted of a denaturation 
step at 95°C for 50 sec, annealing at 60°C for 30 sec 
and extension at 72°C for 2 min. Final elongation was 
carried out at 72°C for 5 min. Amplified products were 
electrophoresed on a 1.3 % agarose gel, purified using 
the High pure PCR purification kit (Roche), digested with 
PmeI and SgfI (Promega) and ligated into pF1A T7 vector 
in order to obtain different b-32 carrying plasmids. E. 
coli competent cells were transformed with recombinant 
plasmids. The correct sequences of the different clones 
were verified by DNA sequencing.
Recombinant and native protein purifications
Single step (KRX) competent cells (L3002 Promega) 
were used for b-32 protein expression. These cells 
incorporate a copy of the T7 RNA polymerase gene 
under control of the rhamnose promoter, which controls 
expression of recombinant proteins. Recombinant KRX 
E.coli colonies were cultivated overnight at 37°C in LB 
medium with ampicillin and 0.4% glucose. Overnight 
cultures were diluted (1:100) in fresh LB medium 
containing ampicillin and grown at 37°C with shaking at 
275 rpm, until they reached an optical density (OD600) 
of 0.4-0.5. Thereafter cultures were incubated at 20°C at 
275 rpm. When cultures reached an OD600 of 0.5-0.6, 
inducers (0.1% L-Rhamnose monohydrate and 1 mmol 
L-1 IPTG) were added and induction was performed 
over night at 20°C and 200 rpm. Cells were harvested by 
centrifugation at 5,000 rpm for 10 min.
B-PERTM (Pierce) extraction buffer was used for extraction 
of recombinant proteins from bacterial cells. Protocols 
for mini and midi-scale bacterial protein extraction 
Figure 1a-PCR primers used for engineering the maize b-32 
sequence for bacterial expression. Sequences in red indicate the 
SgfI restriction site while the blue sequences indicate the PmeI 
restriction site.
Figure 1b-Description of different b-32 plasmids. RIP b-32 contains 
the entire sequence of the b-32 gene (pro-RIP). RIP ∆N is deleted 
for the N-terminal leader sequence (residues 1-16 of pro-RIP). RIP 
∆C contains a deletion of the sequence downstream the linker 
region (186-305 residues of pro-RIP). RIP-∆C (Ala) has a partial 
deletion of the C-terminal domain (residues 286-305 of pro-RIP) 
resulting in polypeptide stopped before the (Ala) sequences. 
Primer combinations, length of fragment obtained in PCR (bp) and 
size of recombinant protein (KDa) are indicated.
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(see instructions B-PERTM) were used for both soluble, 
insoluble and inclusion body purification from total 
bacterial cell lysates. Total protein extracts, from mature 
endosperm of the B73 wt inbred line, were obtained as 
described by Lanzanova et al., (2009).
Fusarium isolates and antifungal bioassays
F. verticillioides strain No. 294 was maintained on Potato 
Dextrose Agar (PDA) medium in Petri dishes, at 26°C with 
a photoperiod of 16h light / 9h dark. An in vitro radial 
growth inhibition bioassay was performed to evaluate 
the inhibitory effect of recombinant RIP-b32 proteins on 
F. verticillioides growth as described in Lanzanova et al., 
2011. Five replicates for each treatment were considered 
for each experiment, and the experiment was performed 
twice.
Fumonisin detection 
After blocking at 7 DAI (Days After Inoculation) the 
fungal growth by placing the plates containing the 
Fusarium mycelium at 4°C, fumonisin content was 
determined according to Ridascreen fumonisin test kit 
(r-Biopharm), as reported by Berardo et al. (2011). Two 
replicates for each treatment were considered for each 
experiment, and the experiment was performed three 
times. 
Statistical analysis
Results of experiments are summarized by means 
accompanied by standard errors (SEs). Statistical 
significance was given by using Student’s t-test with P 
<0.05. 
Results
Recombinant RIP expression in E.coli
The highest recovery of b-32 RIP protein was obtained 
using overnight induction, B-PERTM Reagent (Pierce) 
and midi-scale bacterial protein extraction for both 
soluble, insoluble and inclusion bodies purification 
from total bacterial cell lysates. The recombinant b-32 
RIP protein was expressed and clearly visible on the 
SDS-PAGE gel in all three induced (soluble, insoluble, 
inclusion bodies) fractions (Figure 2, lanes 4, 5, and 
6, respectively) in comparison to uninduced samples 
(Figure 2, lanes 1, 2, and 3, respectively). As a positive 
control, a total protein extract from B73wt endosperm 
was used and allowed to visualize a band of about 32 
KDa, which cross-reacted  with b-32 specific antibodies 
(Figure 2, lane 8).
In order to verify the expression of the recombinant 
b-32 proteins, soluble fractions of induced cells 
transformed with RIP b-32, RIP ∆N, RIP ∆C, and RIP-
∆C (Ala) recombinant b-32 plasmids, respectively were 
analysed by Western blot (Figure 3, lanes 1, 2, 3, and 
4) All recombinant proteins were expressed, although 
to a lesser extend than the wild-type b-32 protein (see 
black arrows in Figure 3). 
Effect of recombinant proteins on F. verticillioides 
growth and fumonisin accumulation
In order to evaluate the inhibitory effect on F. 
verticillioides growth of the recombinant b-32 proteins 
obtained, radial growth inhibition bioassays were 
performed. Petri plates containing 5 ml of PDA (Potato 
Dextrose Agar) were inoculated with 500 µg of the 
different recombinant proteins (RIP b-32, RIP ∆N, 
RIP ∆C and RIP-∆C (Ala) and 100 spores of Fusarium 
per plate. As a control, the growth of Fusarium in the 
presence of B-PER buffer, was measured. The radial 
growth of the pathogen, measured as colony diameter 
from 3 to 5 DAI (Days After Inoculation), in the  presence 
Figure 2- SDS PAGE of recombinant RIP b-32 protein. M: standard 
protein marker; lanes 1-2-3: soluble, insoluble and inclusion bodies 
of uninduced fraction, respectively; lanes 4-5-6: soluble, insoluble 
and inclusion bodies of induced fraction, respectively; lane 7: 
blank; lane 8: B73 wt endosperm protein extract . 
Figure 3-Western blot of the soluble fractions of engineered b-32 
plasmids. M: standard protein marker; lanes 1 to 4: RIP b-32, RIP 
∆N, RIP ∆C, RIP-∆C (Ala), respectively; lane 5: extract from B73 
endosperm. Bands corresponding to recombinant b-32 proteins 
are indicated with arrows.
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or absence of recombinant b-32 protein allowed to 
measure the relative percentage of inhibition of each 
modified b-32 protein. In Table 1, both the growth 
inhibition of Fusarium mycelium relative to the negative 
control and the reduction in fumonisin content relative 
to the negative control at 5 DAI are reported. The 
average colony diameter of the treatments ranged 
from 31.1±3.5 (B-PER) to 33.5±0.2 mm RIP ∆C (Ala). 
Therefore, no significant difference in growth of F. 
verticillioides in the presence of RIP b-32, RIP ∆N, 
RIP ∆C and RIP-∆C (Ala) proteins with respect to the 
control (B-PER) was observed. Conversely, fumonisin 
accumulation was reduced by 16.6% in the presence 
of b-32 protein (Table 1). A more significant reduction 
in fumonisin production was observed with the b-32 
variants carrying a deletion of the N or C terminal 
ends of the mature protein. The highest reduction of 
mycotoxin production (60,1%) was observed in the 
presence of RIP ∆N protein, which carries a deletion 
of the N-terminal leader sequence (residues 1-16 ). 
Reductions of 45% and 44,1% were observed with 
proteins RIP ∆C and RIP-∆C(Ala), respectively, both 
exhibiting a deletion of the C-terminal b-32 sequence.
Discussion
Fumonisins (FBs) are mycotoxins produced in F. 
verticillioides infected maize grain (Berardo et al., 
2011). Attention has focused on FBs because of their 
widespread occurrence, acute toxicity to certain 
livestock, and their potential carcinogenicity. Since 
mycotoxin development occurs mainly in the field, 
strategies are needed to prevent infection of growing 
plants by toxigenic fungi (Duvick et al., 2001). 
Research has been focused on the ability of plant RIP 
proteins to inhibit fungal growth (Nielsen et al., 2001); 
these authors developed a microculture assay useful to 
monitor, during very preliminary stages (18 hours), the 
cellular growth and morphology of fungi upon addition 
of purified RIP proteins. In their study alterations in 
growth and morphology of Aspergillus flavus, a corn 
fungal pathogen, and Aspergillus nidulans, a non-
pathogen strain, suggest that the effect of RIP on A. 
flavus and A. nidulans requires the catalytic ribosome-
inactivating activity of the protein. The inhibitory activity 
of RIPs against normal fungal growth is consistent with 
the biological function to protect the seed from fungal 
invasion during seed germination (data not shown).
Although, in literature, the effect of maize RIP b-32 in 
contrasting Aspergillus development was observed, no 
studies on the effect of this protein in contrasting F. 
verticillioides growth and fumonisin accumulation were 
reported. 
To assess the role of bioactive b-32 recombinant 
proteins in protection against F. verticillioides, a series 
of preliminary in vitro bioassays with recombinant 
RIP b-32 proteins [RIP ∆N, RIP ∆C, and RIP-∆C (Ala)] 
were performed in order to analyze their effect on 
fungal growth and fumonisin accumulation. We have 
observed that all different recombinant b-32 proteins 
did not affect F. verticillioides growth and development 
in an in vitro bioassay, as there were no significant 
differences between the treatments and the control 
(B-PER) from 3 to 5 DAI. An important aspect of maize 
fungal protection regards the capacity of antifungal 
proteins to prevent or reduce mycotoxin production. 
In this respect, it is interesting to note that, although 
no reduction of F. verticillioides mycelium growth was 
observed during our experiments, a clear decrease in 
the accumulation of fumonisins in presence of different 
b-32 recombinant proteins could be shown. Evidence 
for a possible role of b-32 RIP in plant defence was 
attained from the observation that the native protein 
was able to reduce fumonisin accumulation. Moreover, 
the deletion of N or C terminal domains from the 
mature peptide resulted in a greater containment of 
toxin. These observations are in good agreement 
with earlier results reported by Hey et al., 1995. They 
observed that during the activation of maize RIP, the 
removal of the N and C terminal segments increased 
the activity 6 and 5 fold, respectively. 
The protective role of the b-32 protein in favour of 
the safety of the maize kernel was also observed by 
comparing fumonisin accumulation in corn kernels of 
a A69Y opaque-2  line (in which the level of b-32 is 
decreased), with respect to A69Ywt when subjected to 
an artificial inoculation with F. verticillioides (Torri 2011). 
The opaque mutant was not only more susceptible to 
the fungal attack, but also accumulated more fumonisin 











B-PER 31.1 ± 3.5 19150
RIP b-32 32.8 ± 3.1 0%* 15850 16.60% **
RIP ΔN 31.3 ± 1.5 0%* 7633 60.10%**
RIP ΔC 31.9 ± 1.4 0%* 10516 45%**
RIP-ΔC (Ala) 33.5 ± 0.2 0%* 10700 44.10%**
Table 1-Effect of recombinant b-32 proteins on F. verticillioides. 
Radial growth and fumonisin content at 5 Days After Infection 
are indicated. Values are averaged over five replicates. Means 
and standard Errors (SEs) are indicated. Radial growth inhibition 
and fumonisin content were compared to B-PER buffer treated 
Fusarium. Statistical significance was given by using Student’s 
t-test with P <0.05. 
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The preliminary observations reported in this paper are 
encouraging in prospecting the use of maize b-32 RIP 
protein in the containment of fumonisin and possibly 
Fusarium with the aim to improve the quality and safety 
of the maize grain. 
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